Abiopharma

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

📋 NEIL BLUMENTHAL (Director) plans to sell 50K shares of Warby Parker Inc. (at $25.94 each, total $1.3M) Filed: Jan 07, 2026 | ID: 000243

📋 HUNT DOUGLAS M (Officer) plans to sell 5K shares of PUMA BIOTECHNOLOGY, INC. (at $5.88 each, total $29K) Filed: Jan 07, 2026 | ID: 000193

📋 NOUGUES MAXIMO F (Officer) plans to sell 6K shares of PUMA BIOTECHNOLOGY, INC. (at $5.88 each, total $38K) Filed: Jan 07, 2026 | ID: 000192

📋 DAVID GILBOA (Director) plans to sell 75K shares of Warby Parker Inc. (at $25.94 each, total $1.9M) Filed: Jan 07, 2026 | ID: 000239

Iwicki Mark T 🟢 acquired 5.0M shares (1 derivative) of Inhibikase Therapeutics, Inc. (IKT) at $2.01 ($10.0M) Transaction Date: Jan 05, 2026 | Filing ID: 006351

Milanova Tsveta 🟡 adjusted position in 2.9K shares (1 derivative) of AGIOS PHARMACEUTICALS, INC. (AGIO) at $27.02 Transaction Date: Jan 05, 2026 | Filing ID: 000013

📋 MARGARET A HORN (Officer) plans to sell 75K shares of Revolution Medicines, Inc. (at $79.85 each, total $6.0M) Filed: Jan 07, 2026 | ID: 000233

📋 JACK LEE ANDERS (Officer) plans to sell 10K shares of Revolution Medicines, Inc. (at $79.85 each, total $798K) Filed: Jan 07, 2026 | ID: 000232

📋 Halpin Michael (Officer) plans to sell 10K shares of Vericel Corp (at $40.48 each, total $405K) Filed: Jan 07, 2026 | ID: 000191

Cabell Christopher 🟢 acquired 900.1K shares (1 derivative) of Inhibikase Therapeutics, Inc. (IKT) at $2.01 ($1.8M) Transaction Date: Jan 05, 2026 | Filing ID: 006350

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 52 shares of PTC THERAPEUTICS, INC. (at $77.48 each, total $4K) Filed: Jan 07, 2026 | ID: 000190

New SEC Form for ResMed Inc.

McIntyre David 🟢 acquired 986.3K shares (1 derivative) of Inhibikase Therapeutics, Inc. (IKT) at $2.01 ($2.0M) Transaction Date: Jan 05, 2026 | Filing ID: 006343

Clifton R. LaDuane 🟡 adjusted position in 48.5K shares (3 derivative) of ZEVRA THERAPEUTICS, INC. (ZVRA) at $8.96 Transaction Date: Dec 31, 2025 | Filing ID: 000002